Hepatitis C Virus NS3/4A Protease Inhibits Complement Activation by Cleaving Complement Component 4
Seiichi Mawatari(Kagoshima University), Hirohito Tsubouchi(Kagoshima University)
Cited by 17
Related Papers
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Present status of autoimmune hepatitis in Japan: a nationwide survey
|Journal of Gastroenterology|2011|115
Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma
|Blood|2008|75
Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi‐institution analysis
|Journal of Gastroenterology and Hepatology|1995|60